Skip to main content
TipRanks
Go Ultimate75% OFF

Benitec Biopharma (BNTC) Q4 2023 Earnings Report

319 Followers

BNTC Q4 2023 EPS Results

Actual EPS
-$0.01
Consensus EPS
-$3.23
Beat/Miss
Beat by +$3.22
One Year Ago EPS
-$10.54

BNTC Q4 2023 Revenue Results

Actual Revenue
$7,000
Expected Revenue
$0
Beat/Miss
Beat by +$7,000
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2023
Date
09/21/2023
Time
Before Open
Conference Call
Thursday, September 21, 2023
BNTC Upcoming Earnings

Benitec Biopharma's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

BNTC Earnings History

BNTC earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 16, 20262027 (Q1)-0.28--0.22――
Sep 14, 20262026 (Q4)-0.26-0.26-0.4135.80% (+0.14)
May 14, 20262026 (Q3)-0.27-0.24-0.240.00% (+0.00)
Feb 12, 20262026 (Q2)-0.22-0.26-0.3321.21% (+0.07)
Nov 14, 20252026 (Q1)-0.45-0.22-0.4854.17% (+0.26)
Sep 22, 20252025 (Q4)-0.31-0.411.04-138.94% (-1.45)
May 14, 20252025 (Q3)-0.35-0.24-1.6485.37% (+1.40)
Feb 14, 20252025 (Q2)-0.78-0.33-2.6487.50% (+2.31)
Nov 14, 20242025 (Q1)-0.55-0.48-2.7682.61% (+2.28)
Sep 26, 20242024 (Q4)-0.491.04-0.0110500.00% (+1.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed